Pharmaceutical stocks remain attractive in 2022 on strong medicine demand

Friday, Mar 11, 2022

As the COVID-19 pandemic spreads nationwide and is gradually considered an endemic disease that could be treated at home, demand for medicine has increased sharply. Pharmaceutical enterprises is expected to benefit from the situation.

After great results in 2020, pharmaceutical stocks await a good year ahead

Thursday, Feb 25, 2021

Social distancing and strict control at hospitals, and economic recession due to COVID-19 resulted in lower sales of both prescription and non-prescription drugs. However, many companies still witnessed outstanding performance.

Pharmaceutical enterprises enjoy good earnings in Q1

Tuesday, May 26, 2020

Pharmaceutical stocks have attracted investors since the outbreak of the disease due to rising need for medical equipment and drugs.

Pharmaceutical stocks benefit from disease spread

Thursday, Feb 06, 2020

Pharmaceutical stocks are experiencing an upsurge as fears of coronavirus have boosted demand for healthcare products and services, lifting demand for shares.

Bitter pill to swallow for pharmaceutical investors

Thursday, Jan 17, 2019

Pharmaceutical stocks could be a bad bet this year, as the firms are set to report slower earnings growth for 2018.